What is the official source of corporate information for CENTREX PHARMA LIMITED?

This corporate profile is sourced directly from the official registers of the Companies Registry (CR) of HKSAR, Inland Revenue Department (IRD), and public judiciary records under the Companies Ordinance (Cap. 622).

How to retrieve the official Directors Register, Shareholding, and CPA Certified True Copies (CTC)?

To obtain the statutory directors register, shareholding ratios, registered charges, or Certified True Copies (CTC) signed by practicing Hong Kong CPAs, apply through our due diligence platform for rapid delivery.

How to handle TCSP secretarial compliance, Annual Return (NAR1) filing, or bank account opening?

Under HK law, every corporation must maintain a licensed Trust or Company Service Provider (TCSP). Contact our licensed compliance team for statutory secretarial filings and offshore banking facilitation.

UNIQUE BUSINESS IDENTIFIER
UBI 79622584

Live BRN: 79622584 Established 1 Year

CENTREX PHARMA LIMITED

锦成电子商务有限公司

Record Updated: 2026-01-16

Inquiries: 0 Views

Jurisdiction: Hong Kong SAR

CENTREX PHARMA LIMITED (錦成電子商務有限公司) is a Hong Kong corporation duly incorporated under the Companies Ordinance (Cap. 622). Its Business Registration Number (BRN) is 79622584, classified as a Private company limited by shares. Incorporated on 2026-01-12, the entity has maintained continuous statutory operations for 1 year, currently holding an active legal status of Live. The registered office is situated at UNIT L94, ROOM A, 8/F, EXCELSIOR BUILDING,, 68-76 SHA TSUI ROAD,, TSUEN WAN, HONG KONG. You may search and order official filing extracts (NAR1/NNC1/ND2A) or request a full commercial due diligence report for Ultimate Beneficial Owner (UBO) penetration.

I. Corporate Profile & Statutory Registry Records

Statutory Registry Dossier

Official Chinese Name	錦成電子商務有限公司	Official English Name	CENTREX PHARMA LIMITED
Business Reg No. (BRN)	79622584	Company Reg No. (CR)	— (No CR Registered)
Company Category	Private company limited by shares	Incorporation Date	2026-01-12
Current Legal Status	Live	Statutory Filing Cycle	2026-01-12
Registered Office Address	UNIT L94, ROOM A, 8/F, EXCELSIOR BUILDING,, 68-76 SHA TSUI ROAD,, TSUEN WAN, HONG KONG
Significant Controllers (SCR)	Pursuant to Part 12 Division 2A of Cap. 622, SCR records are kept at the registered office. Order our Due Diligence Report to penetrate UBO controllers.

II. Companies Registry Statutory Image Records

Statutory Document Index (Cap. 622)

Document Index Notice: Official image records of target corporation. Click Order to retrieve authentic filing documents in PDF format.

Hong Kong Companies Registry Official Filing Retrieval

Click below to connect with our compliance specialist. The system will immediately query the official Companies Registry database to render the complete archived filing list for this entity.

15-Min Expedited Delivery Official Registry Authentic 7-Day Free Re-Download

Item	Filing Date	Form Ref.	Document Name	Pages	Format	Fee
1	2026-01-15	ND2A	ND2A Statutory Filing	4	PDF	¥28.00
2	2026-01-12	A&A	A&A Statutory Filing	32	PDF	¥28.00
3	2026-01-12	NNC1	NNC1 Statutory Filing	22	PDF	¥28.00
4	2026-01-12	NAR1	NAR1 Statutory Filing	17	PDF	¥28.00

III. Commercial Due Diligence & Regulatory Risk Screening

360° Risk & Compliance Verification

Statutory Licences (32 Regulators) Standard

No active licences recorded under 32 statutory regulators. Operates as general commercial corporation.

Court Litigation & Dockets Judiciary Registry

Screen civil disputes, commercial claims, and criminal dockets across High Court, District Court, and Small Claims Tribunal.

Insolvency & Winding-Up ORO Cap. 6

Cross-check Official Receiver’s Office records for compulsory winding-up petitions, liquidator appointments, and creditor notices.

Office & Address Verification Address Verified

UNIT L94, ROOM A, 8/F, EXCELSIOR BUILDING,, 68-76 SHA TSUI ROAD,, TSUEN WAN, HONG KONG

Need a Full Hong Kong Commercial Due Diligence & Risk Assessment Report?

Our compliance specialists assist with deep corporate penetration, offshore UBO shareholding structures, court litigation dockets, and global sanctions screening.

1v1 Specialist Guidance 360° Full Risk Screening Cap. 486 Privacy Compliant